These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 15812198)
1. Current issues in anticoagulation. Agnelli G Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():2-9. PubMed ID: 15812198 [TBL] [Abstract][Full Text] [Related]
2. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. Mavrakanas T; Bounameaux H Pharmacol Ther; 2011 Apr; 130(1):46-58. PubMed ID: 21185864 [TBL] [Abstract][Full Text] [Related]
3. New oral anticoagulants in development. Weitz JI Thromb Haemost; 2010 Jan; 103(1):62-70. PubMed ID: 20062934 [TBL] [Abstract][Full Text] [Related]
4. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Savelieva I; Bajpai A; Camm AJ Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479 [TBL] [Abstract][Full Text] [Related]
5. The role of ximelagatran in the treatment of venous thromboembolism. Schulman S Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():18-24. PubMed ID: 15812200 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in oral anticoagulation for atrial fibrillation. Singh M; Adigopula S; Patel P; Kiran K; Khosla S Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):395-407. PubMed ID: 20965952 [TBL] [Abstract][Full Text] [Related]
7. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery. Colwell C; Mouret P Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914 [TBL] [Abstract][Full Text] [Related]
8. Ximelagatran: a new oral anticoagulant. Hrebickova L; Nawarskas JJ; Anderson JR Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322 [TBL] [Abstract][Full Text] [Related]
10. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature. Becattini C; Vedovati MC; Agnelli G Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937 [TBL] [Abstract][Full Text] [Related]
11. The need for new oral anticoagulants in clinical practice. Hylek EM J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764 [TBL] [Abstract][Full Text] [Related]
12. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke. Martí-Fàbregas J; Mateo J Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840 [TBL] [Abstract][Full Text] [Related]
13. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
14. New oral anticoagulants in atrial fibrillation. Turpie AG Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568 [TBL] [Abstract][Full Text] [Related]
16. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era.. Mohapatra R; Tran M; Gore JM; Spencer FA Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146 [TBL] [Abstract][Full Text] [Related]
17. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation. Deedwania PC; Huang GW Am J Cardiovasc Drugs; 2011 Aug; 11(4):265-75. PubMed ID: 21740079 [TBL] [Abstract][Full Text] [Related]
18. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins]. Scardi S; Giansante C Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608 [TBL] [Abstract][Full Text] [Related]